SCHEMBL7959596

SCHEMBL7959596

COCN1C(=O)C(N)CN(c2ccccc2)c2ccc(OC)cc21.COc1ccc2c(c1)NC(=O)C(NC(=O)OCc1ccccc1)CN2c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 1/20 0.38
BRD4 O60885 1/20 0.36
BRD2 P25440 1/20 0.36
BRD3 Q15059 1/20 0.36
SCN5A Q14524 1/20 0.35
SCN9A Q15858 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
ACHE P22303 1/20 0.35
NAAA Q02083 2/20 0.35
ALDH1A1 P00352 1/20 0.34
XIAP P98170 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
PREP P48147 2/20 0.34
ASAH1 Q13510 1/20 0.33
PRNP P04156 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6178737 0.89 KCNQ2 (0.45) KCNQ2BRD4BRD2BRD3SCN5A
SCHEMBL7962381 0.80 KYAT1 (0.40) ALDH1A1TP53CYP3A4TSHR
SCHEMBL6176791 0.77 NAAA (0.48) NAAAALDH1A1PREP
SCHEMBL7962689 0.77 BRD4 (0.40) KCNQ2BRD4BRD2BRD3CA1
SCHEMBL17556856 0.73 CA1 (0.47) KCNQ2CA1CA2ACHENAAA
SCHEMBL17557005 0.73 CA1 (0.47) KCNQ2CA1CA2ACHENAAA
SCHEMBL16059873 0.73 CA1 (0.47) KCNQ2CA1CA2ACHENAAA
SCHEMBL6179084 0.71 CA1 (0.32) KCNQ2BRD4BRD2BRD3CA1
Hydrochloric Acid SCHEMBL6177549 0.69 GRM2 (0.34) ALDH1A1
SCHEMBL10735046 0.68 NAAA (0.44) NAAAALDH1A1PREPASAH1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed